HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

General Nutrition Corp.

Latest From General Nutrition Corp.

DMAA Targeted In N.Y. Ban Effort, USP Labs Settles

A New York lawmaker moves to ban DMAA sales in the state, and USP Labs sets aside $2 million to settle class action suit over the product. FDA continues to work with firms that received related warning letters.

Consumer Advertising, Marketing & Sales

DMAA Targeted In N.Y. Ban Effort, USP Labs Settles

A New York lawmaker moves to ban DMAA sales in the state, and USP Labs sets aside $2 million to settle class action suit over the product. FDA continues to work with firms that received related warning letters.

Consumer Advertising, Marketing & Sales

Sales & Earnings In Brief

Cold-EEZE marketing boosts retail reorders; Prestige Brands growth refutes Genomma bid; Mannatech incentivizes new recruits; advertising adds to ChromaDex’s net loss; more Sales and Earnings In Brief.

Consumer Business Strategies

Sales & Earnings In Brief

Cold-EEZE marketing boosts retail reorders; Prestige Brands growth refutes Genomma bid; Mannatech incentivizes new recruits; advertising adds to ChromaDex’s net loss; more Sales and Earnings In Brief.

Consumer Business Strategies
See All

Company Information

  • Industry
  • Services
UsernamePublicRestriction

Register